ProfileGDS4814 / ILMN_1700306
TitleOvarian cancer xenograft tumor response to trastuzumab and pertuzumab
OrganismHomo sapiens


none trastuzumab pertuzumab trastuzumab and pertuzumab GSM780707 GSM780708 GSM780709 GSM780719 GSM780720 GSM780721 GSM780710 GSM780711 GSM780712 GSM780722 GSM780723 GSM780724 GSM780713 GSM780714 GSM780715 GSM780725 GSM780726 GSM780727 GSM780716 GSM780717 GSM780718 GSM780728 GSM780729 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM780707Untreated after 4 days (C1_1)3964.2699
GSM780708Untreated after 4 days (C2_1)5020.2199
GSM780709Untreated after 4 days (C3_1)4708.4999
GSM780719Untreated after 4 days (C1_2)4443.4799
GSM780720Untreated after 4 days (C2_2)4336.7199
GSM780721Untreated after 4 days (C3_2)4480.2599
GSM780710Trastuzumab treated after 4 days (T1_1)5266.5199
GSM780711Trastuzumab treated after 4 days (T2_1)4160.0999
GSM780712Trastuzumab treated after 4 days (T3_1)4814.2799
GSM780722Trastuzumab treated after 4 days (T1_2)5106.0799
GSM780723Trastuzumab treated after 4 days (T2_2)4207.899
GSM780724Trastuzumab treated after 4 days (T3_2)4470.4199
GSM780713Pertuzumab treated after 4 days (P1_1)4480.2599
GSM780714Pertuzumab treated after 4 days (P2_1)4989.8999
GSM780715Pertuzumab treated after 4 days (P3_1)4409.3599
GSM780725Pertuzumab treated after 4 days (P1_2)4387.9699
GSM780726Pertuzumab treated after 4 days (P2_2)4755.599
GSM780727Pertuzumab treated after 4 days (P3_2)4434.9699
GSM780716Trastuzumab and Pertuzumab treated after 4 days (TP1_1)3900.0199
GSM780717Trastuzumab and Pertuzumab treated after 4 days (TP2_1)3943.6899
GSM780718Trastuzumab and Pertuzumab treated after 4 days (TP3_1)4700.9799
GSM780728Trastuzumab and Pertuzumab treated after 4 days (TP1_2)4291.6399
GSM780729Trastuzumab and Pertuzumab treated after 4 days (TP2_2)4429.1299